| Hillview Health Care Ctr | |
| 3501 Park Lane Dr, La Crosse, Wisconsin 54601 | |
| (608) 789-4800 | |
| Name | Hillview Health Care Ctr |
|---|---|
| Location | 3501 Park Lane Dr, La Crosse, Wisconsin |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 110 |
| Occupancy Rate | 69.27% |
| Medicare ID (CCN) | 525426 |
| Legal Business Name | County Of La Crosse |
| Ownership Type | Government - County |
| NPI Number | 1366445793 |
| Organization Name | COUNTY OF LA CROSSE |
| Doing Business As | HILLVIEW HEALTH CARE CENTER |
| Address | 3501 Park Lane Dr, La Crosse, WI 54601 |
| Phone Number | 608-789-4800 |
News Archive
Psoriasis, a chronic disease that causes red, raised patches of skin, is increasingly seen as a systemic disease with links to arthritis and cardiovascular disease. The December issue of Mayo Clinic Women's HealthSource provides an overview of this sometimes embarrassing condition, what's known about it and how it's treated.
Two types of guidance molecules, the attractive and the repulsive, direct the growth of nerve cells to the actual target. The designation of these molecules also describes the exclusive function that was previously attributed to them, namely to show the growing nerve fibers the way. The fundamentally new approach to the research of Prof. Dr. Schwab and his team at the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) is the realization that these guidance molecules have an additional hitherto unknown role in the immune system.
AUXILIO, Inc., the nation's leading Managed Print Services (MPS) company for health care, announced today that it has entered into a three-year service agreement with New Hanover Regional Medical Center, the largest health care provider and largest employer in the greater Wilmington region of North Carolina.
AYOXXA Biosystems GmbH, an international biotechnology company, will develop a multiplex assay to support the treatment of sepsis patients as part of the project "SepsisData.Net.NRW - Digitized Pattern Recognition for Personalized Treatment of Sepsis Patients". The development will be based on the Company's innovative bead-based protein analysis platform LUNARIS™.
UMass Medical School scientist Gang Han, PhD, and his team have designed a new class of molecules used in photodynamic therapy that are able to direct lamp light deep into tissue to kill cancer tumors.
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Psoriasis, a chronic disease that causes red, raised patches of skin, is increasingly seen as a systemic disease with links to arthritis and cardiovascular disease. The December issue of Mayo Clinic Women's HealthSource provides an overview of this sometimes embarrassing condition, what's known about it and how it's treated.
Two types of guidance molecules, the attractive and the repulsive, direct the growth of nerve cells to the actual target. The designation of these molecules also describes the exclusive function that was previously attributed to them, namely to show the growing nerve fibers the way. The fundamentally new approach to the research of Prof. Dr. Schwab and his team at the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) is the realization that these guidance molecules have an additional hitherto unknown role in the immune system.
AUXILIO, Inc., the nation's leading Managed Print Services (MPS) company for health care, announced today that it has entered into a three-year service agreement with New Hanover Regional Medical Center, the largest health care provider and largest employer in the greater Wilmington region of North Carolina.
AYOXXA Biosystems GmbH, an international biotechnology company, will develop a multiplex assay to support the treatment of sepsis patients as part of the project "SepsisData.Net.NRW - Digitized Pattern Recognition for Personalized Treatment of Sepsis Patients". The development will be based on the Company's innovative bead-based protein analysis platform LUNARIS™.
UMass Medical School scientist Gang Han, PhD, and his team have designed a new class of molecules used in photodynamic therapy that are able to direct lamp light deep into tissue to kill cancer tumors.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $20443 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 15.41 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 9.66 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 68.57 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.98 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.85 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 12.54 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 5.97 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.7 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 16.41 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 99.53 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 38.61 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 16.5 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 6.69 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.76 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 71.4 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 83.33 | 82.93 |
News Archive
Psoriasis, a chronic disease that causes red, raised patches of skin, is increasingly seen as a systemic disease with links to arthritis and cardiovascular disease. The December issue of Mayo Clinic Women's HealthSource provides an overview of this sometimes embarrassing condition, what's known about it and how it's treated.
Two types of guidance molecules, the attractive and the repulsive, direct the growth of nerve cells to the actual target. The designation of these molecules also describes the exclusive function that was previously attributed to them, namely to show the growing nerve fibers the way. The fundamentally new approach to the research of Prof. Dr. Schwab and his team at the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) is the realization that these guidance molecules have an additional hitherto unknown role in the immune system.
AUXILIO, Inc., the nation's leading Managed Print Services (MPS) company for health care, announced today that it has entered into a three-year service agreement with New Hanover Regional Medical Center, the largest health care provider and largest employer in the greater Wilmington region of North Carolina.
AYOXXA Biosystems GmbH, an international biotechnology company, will develop a multiplex assay to support the treatment of sepsis patients as part of the project "SepsisData.Net.NRW - Digitized Pattern Recognition for Personalized Treatment of Sepsis Patients". The development will be based on the Company's innovative bead-based protein analysis platform LUNARIS™.
UMass Medical School scientist Gang Han, PhD, and his team have designed a new class of molecules used in photodynamic therapy that are able to direct lamp light deep into tissue to kill cancer tumors.
› Verified 9 days ago
Hillview Health Care Ctr Location: 3501 Park Lane Dr, La Crosse, Wisconsin 54601 Phone: (608) 789-4800 | |
Benedictine Manor Of Lacrosse Location: 2902 East Avenue South, La Crosse, Wisconsin 54601 Phone: (608) 788-9870 | |